(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

COLOPLEX FIGHT CANCER. DETECT EARLY.

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

COLOPLEX FIGHT CANCER. DETECT EARLY.

ST13

US500000087780278

Class

5

Filing

87780278

Registration

6907264

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

54

Latest update

11/08/2023

Trademark type

Combined

Nice classes

5

Filing date

02/01/2018

Registration date

11/22/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/22/2022

Last transaction

11/22/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

03/19/2019

First use in commerce

03/19/2019

Drawing code

3

Owner type

16

Owner location

KNOXVILLE, TN

Examiner

RINKER, ANTHONY

Law office

L20

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the word "COLOPLEX" with "COLO" in blue and "PLEX" in green with the "X" extending down and to the right at an angle with the image of a red and white droplet to the right of "COLOPLEX". The middle of the droplet is white, remains open at the bottom and contains a horizontal crescent design near the top of the opening and the wording "FIGHT CANCER. DETECT EARLY." in blue below "COLOPLEX"; all the foregoing on a white background.

Holders and representatives

Holders

NEW DAY DIAGNOSTICS, LLC
E. C. (pessoa física)

Representatives

Danielle I. Mattessich MERCHANT & GOULD P.C.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detectioncolorectal cancer

Publications

History of USPTO decisions and trademark events.

54 publications found

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

11/08/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

11/22/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

11/22/2022

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

10/19/2022

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

10/18/2022

SUPC

STATEMENT OF USE PROCESSING COMPLETE

09/20/2022

IUAF

USE AMENDMENT FILED

09/16/2022

EISU

TEAS STATEMENT OF USE RECEIVED

09/16/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/19/2022

EX5G

SOU EXTENSION 5 GRANTED

03/18/2022

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

03/18/2022

EXT5

SOU EXTENSION 5 FILED

03/10/2022

EEXT

SOU TEAS EXTENSION RECEIVED

03/10/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

08/26/2021

EX4G

SOU EXTENSION 4 GRANTED

08/24/2021

EXT4

SOU EXTENSION 4 FILED

08/24/2021

EEXT

SOU TEAS EXTENSION RECEIVED

08/24/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/05/2021

EX3G

SOU EXTENSION 3 GRANTED

03/03/2021

EXT3

SOU EXTENSION 3 FILED

03/03/2021

EEXT

SOU TEAS EXTENSION RECEIVED

03/03/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

09/12/2020

EX2G

SOU EXTENSION 2 GRANTED

09/10/2020

EXT2

SOU EXTENSION 2 FILED

09/10/2020

EEXT

SOU TEAS EXTENSION RECEIVED

09/10/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/17/2020

EX1G

SOU EXTENSION 1 GRANTED

03/13/2020

EXT1

SOU EXTENSION 1 FILED

03/13/2020

EEXT

SOU TEAS EXTENSION RECEIVED

03/13/2020

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

09/17/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/23/2019

PUBO

PUBLISHED FOR OPPOSITION

07/23/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/03/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/12/2019

XAEC

EXAMINER'S AMENDMENT ENTERED

06/12/2019

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

06/12/2019

GNEA

EXAMINERS AMENDMENT E-MAILED

06/12/2019

CNEA

EXAMINERS AMENDMENT -WRITTEN

06/12/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/11/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/10/2019

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

06/10/2019

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

12/08/2018

GNFR

FINAL REFUSAL E-MAILED

12/08/2018

CNFR

FINAL REFUSAL WRITTEN

12/08/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/16/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/16/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/16/2018

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/16/2018

GNRT

NON-FINAL ACTION E-MAILED

05/16/2018

CNRT

NON-FINAL ACTION WRITTEN

05/16/2018

DOCK

ASSIGNED TO EXAMINER

05/15/2018

MDSM

NOTICE OF DESIGN SEARCH CODE E-MAILED

02/13/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/11/2018

NWAP

NEW APPLICATION ENTERED

02/05/2018

Continuous trademark protection

Get notified about every new filing that threatens COLOPLEX FIGHT CANCER. DETECT EARLY. or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.